Cite
HARVARD Citation
Moens, A. et al. (2020). Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study. Alimentary pharmacology & therapeutics. 51 (1), pp. 129-138. [Online].